索诺瓦首次亮相进博，全链条创新方案赋能健康聆听未来

Core Insights - Sonova made its debut at the 8th China International Import Expo, showcasing a comprehensive range of innovative hearing health solutions, including the Asia premiere of the Phonak AI hearing aids and MRI-compatible cochlear implant technology [1][2] Group 1: Commitment to the Chinese Market - Sonova emphasizes its commitment to deepening its presence in the Chinese market, focusing on hearing health as a critical aspect of public health, especially in light of the "Healthy China 2030" strategy [2][6] - The company has established a complete ecosystem in China that encompasses research and development, production, and service, aiming to provide a full lifecycle hearing health management solution [2][3] Group 2: Innovative Solutions and Product Offerings - At the expo, Sonova presented four key segments: hearing devices, cochlear implants, hearing care services, and consumer hearing products, showcasing its systematic innovation capabilities [3][4] - The Phonak Audeo Paradise AI hearing aids, featuring advanced dual-chip architecture, were highlighted as a key product, enhancing the listening experience through sophisticated algorithms [3][4] - The exhibition also included the AB Ultra 3D cochlear implant, which is compatible with 3.0T MRI technology, ensuring safer clinical procedures for patients [3] Group 3: Strategic Partnerships - Sonova signed a strategic cooperation memorandum with Shanghai Pharmaceuticals, aiming to enhance the hearing health service system and accelerate the delivery of innovative solutions to Chinese patients [1][6] - The partnership is expected to leverage synergies in the hearing health and cochlear implant sectors, contributing to a healthier ecosystem for hearing health in China [6]